Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Anastrozole MeSH Descriptor Data 2025


MeSH Heading
Anastrozole
Tree Number(s)
D02.626.218
D03.383.129.799.275
Unique ID
D000077384
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077384
Scope Note
A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women.
Entry Term(s)
2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)
Anastrazole
Arimidex
ICI D1033
ZD-1033
ZD1033
Zeneca ZD 1033
Pharm Action
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Registry Numbers
2Z07MYW1AZ
0
Related Numbers
120511-73-1
CAS Type 1 Name
1,3-Benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-
Public MeSH Note
2019; ANASTROZOLE was indexed under NITRILES and TRIAZOLES 1994-2018
History Note
2019 (1994)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/02/27
Anastrozole Preferred
ICI D1033 Narrower
ZD-1033 Narrower
Arimidex Narrower
page delivered in 0.144s